TAF15 mediates ROP16-induced apoptosis and cell cycle arrest in lung cancer

Guangqi Li1,2, Mei Tian3, Yuning Zhou4

  • 1Medical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Parasites & Vectors
|July 19, 2025
PubMed
Abstract

Insights

Toxoplasma gondii ROP16 (ROP16) protein, specifically types I and III, induces lung adenocarcinoma cell death and cell cycle arrest by interacting with host TAF15. This interaction highlights the oncosuppressive potential of parasite proteins.

Area of Science:

  • Molecular biology
  • Cancer research
  • Parasitology

Background:

  • Lung adenocarcinoma is a major cause of cancer mortality.
  • Toxoplasma gondii secretory proteins, like ROP16, are investigated for their biological functions.
  • Understanding host-pathogen interactions is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the interaction between ROP16 and TAF15 in A549 lung adenocarcinoma cells.
  • To determine the effects of this interaction on apoptosis and cell cycle regulation.
  • To explore the potential oncosuppressive role of parasite-derived proteins.

Main Methods:

  • Established lentivirus-infected A549 cell lines overexpressing ROP16 types I, II, and III.
  • Identified ROP16 interacting proteins using co-immunoprecipitation (Co-IP) and liquid chromatography-mass spectrometry (LC-MS).
  • Confirmed ROP16-TAF15 interaction and assessed apoptosis and cell cycle changes via flow cytometry, RT-qPCR, and western blotting after TAF15 silencing.

Main Results:

  • Confirmed interaction between ROP16 and TAF15.
  • Type I and III ROP16 promoted apoptosis and cell cycle arrest in A549 cells, modulating key regulatory proteins.
  • Type II ROP16 had no significant effect; TAF15 silencing attenuated the effects of type I/III ROP16.

Conclusions:

  • Type I/III ROP16 induce apoptosis and cell cycle arrest in lung adenocarcinoma cells via interaction with TAF15.
  • This interaction reveals a mechanism where parasite effectors hijack host transcriptional regulators.
  • Toxoplasma gondii-derived secretory proteins exhibit oncosuppressive potential against cancer cell survival.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K